1. Home
  2. NXN vs CGTX Comparison

NXN vs CGTX Comparison

Compare NXN & CGTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NXN
  • CGTX
  • Stock Information
  • Founded
  • NXN 1992
  • CGTX 2007
  • Country
  • NXN United States
  • CGTX United States
  • Employees
  • NXN N/A
  • CGTX N/A
  • Industry
  • NXN Trusts Except Educational Religious and Charitable
  • CGTX Biotechnology: Pharmaceutical Preparations
  • Sector
  • NXN Finance
  • CGTX Health Care
  • Exchange
  • NXN Nasdaq
  • CGTX Nasdaq
  • Market Cap
  • NXN 45.4M
  • CGTX 53.4M
  • IPO Year
  • NXN N/A
  • CGTX 2021
  • Fundamental
  • Price
  • NXN $11.72
  • CGTX $2.50
  • Analyst Decision
  • NXN
  • CGTX Strong Buy
  • Analyst Count
  • NXN 0
  • CGTX 3
  • Target Price
  • NXN N/A
  • CGTX $2.83
  • AVG Volume (30 Days)
  • NXN 9.7K
  • CGTX 11.7M
  • Earning Date
  • NXN 01-01-0001
  • CGTX 08-07-2025
  • Dividend Yield
  • NXN 4.23%
  • CGTX N/A
  • EPS Growth
  • NXN N/A
  • CGTX N/A
  • EPS
  • NXN 0.24
  • CGTX N/A
  • Revenue
  • NXN N/A
  • CGTX N/A
  • Revenue This Year
  • NXN N/A
  • CGTX N/A
  • Revenue Next Year
  • NXN N/A
  • CGTX N/A
  • P/E Ratio
  • NXN $48.42
  • CGTX N/A
  • Revenue Growth
  • NXN N/A
  • CGTX N/A
  • 52 Week Low
  • NXN $10.64
  • CGTX $0.22
  • 52 Week High
  • NXN $12.45
  • CGTX $3.83
  • Technical
  • Relative Strength Index (RSI)
  • NXN 58.89
  • CGTX 67.85
  • Support Level
  • NXN $11.67
  • CGTX $2.62
  • Resistance Level
  • NXN $11.78
  • CGTX $3.83
  • Average True Range (ATR)
  • NXN 0.08
  • CGTX 0.42
  • MACD
  • NXN 0.00
  • CGTX 0.14
  • Stochastic Oscillator
  • NXN 77.74
  • CGTX 60.26

About NXN Nuveen New York Select Tax-Free Income Portfolio

Nuveen NY Select Tax-Free Income Port is a diversified closed-end management investment company. Its investment objective are to provide current income exempt from regular federal and New Jersey income tax, and to enhance portfolio value relative to the municipal bond market by investing in tax-exempt municipal bonds that the Fund's investment adviser believes are underrated or undervalued or that represent municipal market sectors that are undervalued.

About CGTX Cognition Therapeutics Inc.

Cognition Therapeutics Inc is a clinical-stage biopharmaceutical company engaged in the discovery and development of, small-molecule therapeutics targeting age-related degenerative diseases and disorders of the central nervous system and retina. Its product candidate CT1812, is an orally delivered, small-molecule antagonist designed to penetrate the blood-brain barrier and bind selectively to the S2R complex.

Share on Social Networks: